Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Rectal Neoplasms 10 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Uterine Cervical Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Adenocarcinoma Of Esophagus 5 Squamous Cell Carcinoma of Head and Neck 4 Neuroblastoma 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Colonic Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Multiple Myeloma 2 Melanoma 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2

Interventions

Doxorubicin 8 Ifosfamide 6 Radiotherapy 4 Dacarbazine 3 Trabectedin 2 Filgrastim 2 pegfilgrastim 1 olaratumab 1 indolepropanol phosphate 1 anlotinib 1 Watchful Waiting 1 Tablets 1 Surgical Procedures, Operative 1 Rosuvastatin Calcium 1 Radiotherapy, Conformal 1 PM 01183 1 Observation 1 Neoadjuvant Therapy 1 Midazolam 1 Etoposide 1 Digoxin 1 Diathermy 1 Combined Modality Therapy 1 Chemotherapy, Adjuvant 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyosarcoma × Neoadjuvant Therapy × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡